Wells Fargo’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-310,346
| Closed | -$962K | – | 8397 |
|
|
2021
Q4 | $962K | Sell |
310,346
-363,142
| -54% | -$1.22M | ﹤0.01% | 4142 |
|
|
2021
Q3 | $2.43M | Buy |
673,488
+506,335
| +303% | +$1.91M | ﹤0.01% | 3488 |
|
|
2021
Q2 | $598K | Sell |
167,153
-232,783
| -58% | -$821K | ﹤0.01% | 4527 |
|
|
2021
Q1 | $1.56M | Sell |
399,936
-9,068
| -2% | -$37.5K | ﹤0.01% | 3915 |
|
|
2020
Q4 | $1.72M | Buy |
409,004
+19,320
| +5% | +$74.5K | ﹤0.01% | 3610 |
|
|
2020
Q3 | $1.45M | Sell |
389,684
-4,961
| -1% | -$21.1K | ﹤0.01% | 3574 |
|
|
2020
Q2 | $1.72M | Buy |
394,645
+94,340
| +31% | +$424K | ﹤0.01% | 3376 |
|
|
2020
Q1 | $1.14M | Buy |
300,305
+127,021
| +73% | +$624K | ﹤0.01% | 3463 |
|
|
2019
Q4 | $1.1M | Buy |
173,284
+35,703
| +26% | +$210K | ﹤0.01% | 3800 |
|
|
2019
Q3 | $580K | Buy |
137,581
+53,395
| +63% | +$228K | ﹤0.01% | 4266 |
|
|
2019
Q2 | $391K | Buy |
84,186
+29,679
| +54% | +$138K | ﹤0.01% | 4554 |
|
|
2019
Q1 | $290K | Sell |
54,507
-17,188
| -24% | -$78.5K | ﹤0.01% | 4641 |
|
|
2018
Q4 | $266K | Sell |
71,695
-46,365
| -39% | -$163K | ﹤0.01% | 4745 |
|
|
2018
Q3 | $331K | Buy |
118,060
+64,803
| +122% | +$182K | ﹤0.01% | 4720 |
|
|
2018
Q2 | $157K | Sell |
53,257
-14,156
| -21% | -$33.6K | ﹤0.01% | 5158 |
|
|
2018
Q1 | $151K | Buy |
67,413
+332
| +0.5% | +$777 | ﹤0.01% | 5124 |
|
|
2017
Q4 | $198K | Buy |
67,081
+31,575
| +89% | +$87.3K | ﹤0.01% | 4960 |
|
|
2017
Q3 | $105K | Buy |
35,506
+20,599
| +138% | +$62.7K | ﹤0.01% | 5218 |
|
|
2017
Q2 | $42K | Hold |
14,907
| – | – | ﹤0.01% | 5441 |
|
|
2017
Q1 | $28K | Buy |
14,907
+13,600
| +1,041% | +$26.2K | ﹤0.01% | 5634 |
|
|
2016
Q4 | $2K | Sell |
1,307
-7,923
| -86% | -$16.2K | ﹤0.01% | 6132 |
|
|
2016
Q3 | $25K | Buy |
9,230
+923
| +11% | +$2.34K | ﹤0.01% | 5544 |
|
|
2016
Q2 | $20K | Sell |
8,307
-21,704
| -72% | -$59.9K | ﹤0.01% | 5504 |
|
|
2016
Q1 | $97K | Buy |
30,011
+119
| +0.4% | +$440 | ﹤0.01% | 4854 |
|
|
2015
Q4 | $143K | Buy |
29,892
+2,460
| +9% | +$13.9K | ﹤0.01% | 4681 |
|
|
2015
Q3 | $152K | Sell |
27,432
-22,334
| -45% | -$165K | ﹤0.01% | 4624 |
|
|
2015
Q2 | $396K | Sell |
49,766
-1,348,335
| -96% | -$11.6M | ﹤0.01% | 4229 |
|
|
2015
Q1 | $14.7M | Buy |
1,398,101
+248,456
| +22% | +$3.39M | 0.01% | 1559 |
|
|
2014
Q4 | $13.8M | Buy |
1,149,645
+592,361
| +106% | +$9M | 0.01% | 1563 |
|
|
2014
Q3 | $9.52M | Buy |
557,284
+534,533
| +2,349% | +$7.76M | ﹤0.01% | 1824 |
|
|
2014
Q2 | $275K | Buy |
22,751
+20,551
| +934% | +$195K | ﹤0.01% | 4228 |
|
|
2014
Q1 | $19K | Buy |
+2,200
| New | +$17.8K | ﹤0.01% | 5247 |
|
Other funds holding BDSI
Wells Fargo's BDSI Position: Q1 2022 in Review
Wells Fargo sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 310,346 shares — an estimated $962K sold.
Wells Fargo first reported a position in BDSI in Q1 2014 and held it in 32 quarters. The position peaked at $14.7M in Q1 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Wells Fargo reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Wells Fargo sold 310,346 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $962K.
- Wells Fargo first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 32 quarters.
- Wells Fargo's BioDelivery Sciences International, Inc. position peaked at $14.7M in Q1 2015.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Wells Fargo's 13F filing for Q1 2022, filed 16 May 2022.